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Summary
Medicinal mushrooms have profound health-promoting benefits. Recently, a number
of substances of mushroom origin have been isolated, identified and shown to have physi-
ological activities, such as antitumor, immunomodulating, cardiovascular, antihypercholes-
terolemia, antibacterial, antiviral, antiparasitic, hepatoprotective, and antidiabetic activities.
Currently, commercial products from medicinal mushrooms are mostly obtained through
the field-cultivation of the fruiting body. However, in this case it is difficult to control the
quality of the final product. Submerged fermentation of the mycelial form of mushroom-
-producing fungi has received much attention as a promising alternative for efficient pro-
duction of the biomass of medicinal mushrooms and their active metabolites. However, in
order for the production to be successful at industrial scale, various technical problems
need to be solved, including characterization of the variations that occur during the sub-
merged cultivation of mushrooms in bioreactors and their effects on growth and product
formation. This review outlines the major factors that affect the submerged cultivation of
mushrooms in bioreactors, including oxygen supply, shear and mixing, morphology and
rheology, as well as two-stage cultivation strategies and high-cell-density cultivation strat-
egies such as fed-batch fermentation.
Key words: mushroom, macrofungi, submerged fermentation, bioreactor, bioactive metabo-
lites, fed-batch fermentation, oxygen transfer, shear and mixing, morphology and rheology,
two-stage cultivation process
Introduction
Mushrooms have long been regarded as effective
medicines for the treatment of various human diseases.
The medicinal properties are due to various cellular com-
ponents and secondary metabolites, which have been iso-
lated and identified from the fruiting-body, culture my-
celium and culture broth of mushrooms and shown to
have promising antitumor, immunomodulating, cardio-
vascular and hypercholesterolemia, antiviral, antibacte-
rial, and antiparasitic effects (1–3). The number of mush-
room species on Earth is estimated at 140 000, yet only
10 % (approximately 14 000 named species) are known
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(4). Few have been studied thoroughly from the stand-
point of their commercial potential. Less than 25 species
of mushrooms are accepted widely as food and even
fewer have attained the status of items of commerce.
This is unfortunate, because mushrooms comprise a vast
and yet largely untapped source of potential new phar-
maceutical products. In particular, and most importantly
for modern medicine, they represent a source of new
polysaccharides with antitumor and immunostimulating
properties. Medicinal mushrooms are viewed as a rap-
idly developing area of biotechnology for cancer and
other therapies (3).
ISSN 1330-9862
There is a growing market for the products derived
from medicinal mushrooms. Currently, commercial mush-
room products are mostly derived from the fruiting body
of field-cultivated mushrooms. However, it usually takes
several months to cultivate the fruiting body and it is
difficult to control the quality of the final product, as it
is subject to the vagaries of the weather and pests. Sub-
merged culture of medicinal mushrooms is a promising
alternative for efficient production of mycelium and me-
tabolites and has received increasing attention around
the world. However, in spite of several decades of ef-
forts, the production of secondary metabolites by sub-
merged culture of mushrooms is still facing many bio-
logical, physiological and engineering limitations. The
lack of information on submerged cultivation of mush-
rooms in bioreactors is significant when compared to
the relatively large body of information about the sub-
merged culture of streptomycetes and microfungi.
This review focuses on the special challenges, cur-
rent state-of-the-art, and future prospects of submerged
cultivation of medicinal mushrooms to produce myce-
lium and bioactive metabolites. It highlights the need to
overcome the difficulties in oxygen transfer and mixing
that are caused by the changes in broth rheology that
typically occur during the fermentation and also the use
of fed-batch fermentation strategies to maximize prod-
uct formation. However, first a brief overview of the
products from mushrooms that have been produced by
submerged culture will be given.
Bioactive Metabolites Produced by
Submerged Cultivation of Mushrooms
A number of bioactive metabolites of higher basi-
diomycetes have been produced by submerged cultiva-
tion in bioreactors, as shown in Table 1 (5–19). The fol-
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Table 1. Current state of cultivation of mushrooms/macrofungi in bioreactors
Mushroom Production Scale Results
Agaricus brasiliensis
(synonym: Agaricus
blazei ss. Heinem.) (5)
Polysaccharide
5-L agitated bioreactor with two six-bladed
turbine impellers
(1.67±0.08) g/L





5-L stirred-tank reactor (KoBioTech Co., Seoul, Korea)
working volume of 3 L
3.0 g/L
Antrodia camphorata (7,8)
EPS 5-L bioreactor (B. Braun, Germany) 148 mg/L
Polysaccharide
500-L fermenting tank containing 350 L
of cultural medium
23.2 % (yield)
Total polyphenols 71 mg/g
Crude triterpenoids 108 mg/g
Auricularia polytricha (9) Exobiopolymer
5-L stirred-tank fermentor (KoBioTech Co., Seoul,
Korea) with working volume of 3 L
3.1 g/L
Collybia maculate (10) EPS 5-L stirred-tank reactor with working volume of 3 L 3.94 g/L
Cordyceps militaris (11) Cordycepin
30-L centrifugal impeller bioreactor (CIB) with
working volume of 21 L
188.3 mg/L
Cordyceps sinensis (12)
Cordycepin 5-L bioreactor (TopBio, Taiwan) with working






(KoBioTech Co., Incheon, Korea)
5.3 g/L
5-L airlift bioreactor
(Best Korea Co. Ltd., Daejeon, Korea)
4.53 g/L





(stirred type, KoBioTech Co., Seoul, Korea)
0.495 g/L
Phellinus
(P. baumii, P. gilvus
and P. linteus) (16)
EPS
5-L stirred-tank reactor (KoBioTech Co., Seoul, Korea)
with working volume of 3 L
P. baumii 3.59 g/L
P. gilvus 5.30 g/L
P. linteus 2.43 g/L
Phellinus gilvus (17) EPS
5-L stirred-tank reactor (KoBioTech Co., Seoul, Korea)
with working volume of 3 L
5.3 g/L
Sarcodon aspratus (18) EPS
5-L stirred-tank reactor (KoBioTech Co., Seoul, Korea)





12-L standard bubble column fermentor with working
volume of 10 L
Yield<20 %
8-L external-loop airlift column fermentor with
working volume of 7.2 L
Yield>40 %
5-L airlift reactor (Best Korea Co Ltd., Daejeon, Korea) 3.05 g/L
EPS – extracellular polysaccharide
lowing subsections briefly outline the key characteristics
of each group of metabolites and their biological activi-
ties.
Polysaccharides
The fruiting bodies of many basidiomycetes, if not
all, contain biologically active polysaccharides. Data on
mushroom polysaccharides have been collected from
651 species and 7 infraspecific taxa from 182 genera of
higher hetero- and homobasidiomycetes. In Japan, Rus-
sia, China, and the USA, several different polysaccha-
ride antitumor agents have been developed from the
fruiting body, cultured mycelia, and culture broth of va-
rious medicinal mushrooms including Lentinus edodes, Ga-
noderma lucidum, Schizophyllum commune, Trametes versi-
color, Inonotus obliquus, and Flammulina velutipes (2,20).
These polysaccharides are of different chemical com-
positions, with most belonging to the group of b-glu-
cans; these have b-(1®3) linkages in the main chain of
the glucan and additional b-(1®6) branch points that
are needed for their antitumor action. High molecular
mass glucans appear to be more effective than those of
low molecular mass. Most of the clinical evidence for
antitumor activity comes from three commercial poly-
saccharides, namely lentinan produced by Lentinus edo-
des, PSK (polysaccharide krestin) produced by Coriolus
versicolor, and schizophyllan produced by Schizophyllum
commune. Their activity is especially beneficial in clinics
when used in conjunction with chemotherapy. Mush-
room polysaccharides prevent oncogenesis, show anti-
tumor activity against various allogeneic and syngeneic
tumors, and prevent tumor metastasis. They do not at-
tack cancer cells directly, but produce their antitumor ef-
fects by activating different immune responses in the
host. The antitumor action of polysaccharides requires
an intact T cell component; their activity is mediated
through a thymus-dependent immune mechanism (2).
Terpenoids
Terpenoids have been produced from G. lucidum, al-
though other species are being increasingly investigated
for the production of triterpenoids and related steroids.
Terpenoids are comprised of four groups: (i) volatile
mono- and sesquiterpenes (essential oils) (C10 and C15),
(ii) less volatile diterpenes (C20), (iii) non-volatile triter-
penoids and sterols (C30), and (iv) carotenoid pigments
(C40) (21,22). Ziegenbein et al. (21) and Zhou et al. (22)
have summarized the structure and bioactivity of terpe-
noids in G. lucidum. Tri-, di- and monoterpenoids are dis-
cussed separately in the following subsections.
Triterpenoids
The physicochemical properties of over 130 lanostane-
-type triterpenoids have been described since ganoderic
acid A and B were first described (22). The biological ac-
tivities of triterpenes from G. lucidum have received re-
cent attention, with three different types of activity be-
ing demonstrated. Firstly, a triterpene fraction extracted
from the mycelium inhibited growth of human hepato-
ma cells (23). Secondly, the triterpene fraction of myce-
lial extracts, which contained ganoderic acids A, B, C and
D, lucidenic acid B and ganodermanotriol, showed anti-
oxidant activities against pyrogallol-induced oxidation of
erythrocyte membrane and Fe(II)-ascorbic-acid-induced
lipid peroxidation in liver mitochondria (24). Thirdly, tri-
terpenes isolated from fruiting bodies, such as ganoderic
acid, ganoderiol B and ganodermanontriol, showed sig-
nificant anti-HIV-1 and anti-HIV-1 protease activity (25).
Diterpenoids
Diterpenoids have one of four types of carbon skele-
tons: (i) cyathane-type (Fig. 1); In 1965, a new bird’s nest
fungus of the genus Cyathus was discovered in Canada
and named Cyathus helenae. Ayer and Browne (26) proved
that the bioactive component of Cyathus helenae belonged
to a new class of diterpenoids, which have been named
the cyathins. Since the 1980s, a series of new compounds
with cyathane-type carbon skeletons have been found in
the fruiting bodies of Sarcodon scabrosum and the culture
broths of Hericium erinaceus and Hericium ramosum. In
2000, a new cyathane-xyloside, erinacine P, was isolated
from the mycelium of the basidiomycete Hericium erina-
ceum. Since its aglycon closely resembles typical cya-
thane diterpenoids, this glycoside seems to be an impor-
tant metabolite in the biosynthesis of erinacines and
striatins; (ii) trichoaurantiane-type (Fig. 2); This type of
carbon skeleton was first reported in 1995, and has only
been found in a few basidiomycetous fungi, including
Tricholoma aurantium and Lepista sordida (27); (iii) sphae-














Fig. 2. The structure of trichoaurantianolide A (a typical diter-
penoid with a trichoaurantiane–type carbon skeleton)
roane-type (Fig. 3); This type of carbon skeleton has only
been found in Sphaerococcus coronopifolius and algae. In
1998, a new compound, tintinnadiol, was found in the
fruiting body of Mycena tintinnabulum, and was shown
to have a sphaeroane-type carbon skeleton (28); (iv) other
styles; In the 1950s, some other compounds with new
skeleton types were extracted from the basidiomycete
Pleurotus mutilis and from Drosophila subatrata, and were
shown to have antimicrobial activity (29).
Many papers have shown that diterpenoids can be
inducers of nerve growth factor and have antimicrobial
and antitumor activity. They can also inhibit the synthe-
sis of squalene synthase and act as agonists of the
opioid receptor (29).
Sesquiterpenoids and monoterpenoids
There is relatively little research into monoterpenes
in mushrooms in comparison with other terpenes. A few
papers have demonstrated that sesquiterpenoids can pro-
mote the synthesis of nerve growth factor (30) and have
insecticidal activity (31). A new lactarane sesquiterpene
was isolated from a mushroom of the Russulaceae family,
Lactarius vellereus, and found to promote radicle elonga-
tion in lettuce seedlings (32). Five monoterpene alcohols
have been isolated from the mushroom Dictyophora in-
dusiata (33). Finally, a new monoterpene isolated from
the basidiomycete Cheimonophyilum candidissimum showed
nematicidal activity to Caenorhabditis elegans (34).
Cordycepin
Cordycepin (3’-deoxyadenosine), which comes from
the Chinese medicinal fungus Cordyceps militaris (Linn.)
Link, was extracted from the culture broth of this fun-
gus by Cunningham et al. in 1951 (35). It is the first bac-
teriophage nucleotide separated from fungi and it has
been recognized as a kind of cytotoxin (36). Cordycepin
has antitumor, antibacterial, antifungal, antileukemic and
antiviral activities and inhibits the activity of protein ki-
nase (36,37). With respect to its antitumor activity, cor-
dycepin restrains the growth of the mouse Ehrlich as-
cites tumor cell, HeLa human cervical carcinoma cell and
Lewis lung cancer (38,39).
Ergosterol
Ergosterol is an important chemical in the pharma-
ceutical and chemical industry. It is the precursor of vi-
tamin D; under ultraviolet radiation it can be converted
into cortisone and progestin. Ergosterol is an important
part of the fungal cell membrane, playing a role in main-
taining membrane integrity, the activity of membrane-
-associated enzymes, and the fluidity of the membrane
and the generation of cellular energy. Fruiting bodies of
the medicinal mushroom Agaricus brasiliensis are relati-
vely rich in ergosterol (5), which has also been found in
Cordyceps militaris. However, commercial production of
ergosterol still involves either yeast fermentation or ex-
traction from the waste mycelium resulting from penicil-
lin production.
Ceramide
Ceramide is a functional element that can be added
to foods and cosmetics. It has effects such as improving
immunity, preventing cancer and combating existing can-
cers. Its function as an effective moisturizing agent gives
it the potential to be an important ingredient in cosme-
tics. Ceramide-containing products can dramatically in-
crease the skin’s hydration level, repair the cutaneous
barrier, prevent vital moisture loss, and contribute to re-
ducing dry flaky skin and aged appearance (40).
Four new phytosphingosine-type ceramides have
been isolated from the fruiting bodies of Grifola frondosa
(41). In 2001, a new C18-phytosphingosine ceramide
containing a non-hydroxy fatty acid, armillaramide, was
isolated from the fruiting bodies of the basidiomycete
Armillaria mellea (42).
Submerged Cultivation of Mushrooms in
Bioreactors
The bioactive metabolites of mushrooms can poten-
tially be produced industrially by submerged cultiva-
tion, but success on a commercial scale depends on the
cost compared with existing technology and whether in-
dustry sees any economic advantages. Expansion of the
use of this technology will be facilitated by increases in
product yields and the development of novel produc-
tion systems.
The submerged cultivation of mushrooms is charac-
terized by an increase in broth viscosity with time, which
can be due to one or more factors, including the increase
in cell concentration within the bioreactor, changes in
growth morphology, or the production of extracellular
products that alter the rheological character of the cul-
ture fluid. Such viscosity increases are usually viewed
by the process operator as an undesirable but inevitable
phenomenon (43–46), since they cause difficulties in the
supply of oxygen, in the removal of carbon dioxide, and
in the provision of adequate agitation. In the following
sections we discuss strategies that have been developed
for the cultivation of mushrooms in order to overcome
the difficulties caused by viscosity increases and to max-
imize the formation of the desired metabolites.
Within these sections, special attention is given to
Ganoderma lucidum (Fr.) Krast (Polyporaceae), one of the
most famous traditional Chinese medicinal mushrooms,




Fig. 3. The structure of tintinnadiol (a typical diterpenoid with
a sphaeroane–type carbon skeleton)
known for more than 2000 years and used as a popular
folk medicine to treat many diseases, such as hepatitis,
hypertension, hypercholesterolemia and gastric cancer
(24,47,48). The polysaccharides isolated from the fruiting
body and culture mycelium of G. lucidum also have
antitumor activities (48). Recently, ganoderic acids have
been isolated from the fruiting bodies and cultured my-
celium of G. lucidum and biological functions such as
anti-HIV-1 and anti-HIV-1 protease have been reported
(25,49). As a result of this biotechnological potential,
there has been a significant interest in developing pro-
cesses for the culture of G. lucidum in bioreactors.
Fed-batch fermentation in stirred-tank bioreactors
Tang and Zhong (50) developed an efficient fed-
-batch fermentation process for simultaneous production
of ganoderic acid (GA) and polysaccharides by G. luci-
dum. The initial studies focused on the effects of carbon
source and initial sugar concentration on the process. Su-
crose was a suitable carbon source for the production of
extracellular polysaccharides (EPS), although the cells did
not grow well. Lactose promoted good cell growth and
production of GA and intracellular polysaccharides (IPS).
When the initial lactose concentration exceeded 35 g/L,
the GA accumulation was decreased; GA production was
remarkably improved by using a low level of initial lac-
tose and feeding lactose in pulses in such a manner as
to maintain its concentration in the culture broth be-
tween 5 and 10 g/L. The fed-batch fermentation process
in shake flasks was successfully reproduced in stirred
bioreactors (STR) with dissolved oxygen (DO) controlled
to be between 20 and 35 % of air saturation during fer-
mentation. The maximum cell density reached 22 and 21
g/L, EPS reached 0.87 and 0.75 g/L, while IPS reached
2.5 and 2.4 g/L, in the STR and flask, respectively. GA
reached 367 and 298 mg/L in the STR and flask, respec-
tively, with the corresponding productivities being 30
and 14 mg/(L·day). Not only the cell density but also
the content, production and productivity of GA and IPS
obtained in this work are the highest values reported in
agitated cultures of G. lucidum. This appears to be due
to the fact that the low lactose concentration maintained
during the fermentation avoided the inhibitory effects of
high lactose levels on the production of GA.
Similar processes have been developed for other or-
ganisms. A fed-batch fermentation of Agaricus brasiliensis
enhanced growth and the production of EPS and ergos-
terol (5). In the case of Ganoderma resinaceum (51), the
maximum concentrations of mycelial biomass (42 g/L)
and EPS (4.6 g/L) were obtained when 50 g/L of glu-
cose were fed on day 6. By optimizing the time and the
amount of NH4
+ feeding to the fed-batch, Mao and
Zhong (52) increased the production of cordycepin by
the medicinal mushroom Cordyceps militaris from 209
mg/L in batch culture to 346 mg/L in fed-batch culture.
Oxygen supply
Tang and Zhong (53) studied the effect of oxygen
supply on growth and the production of polysaccha-
rides and ganoderic acid (GA) by Ganoderma lucidum,
over a range of initial values of the volumetric oxygen
transfer coefficient (KLa) from 16.4 to 96.0 h
–1. In terms
of biomass and intracellular polysaccharide (IPS) pro-
duction, the best initial KLa was 78.2 h
–1, giving a bio-
mass concentration of 15.6 g/L, an IPS yield of 2.19 g/L
and an IPS productivity of 217 mg/(L·day). An increase
of initial KLa to 96.0 h
–1 led to the formation of larger
mycelial aggregates. This increase in the initial KLa also
maximized the yield and productivity of GA, both of
these being 1.8-fold greater than the values obtained
with an initial KLa of 16.4 h
–1. The effects of KLa on the
performance of the cultivation process are mediated by
their effects on the dissolved oxygen (DO) tension. This
parameter was studied more directly by maintaining the
DO constant during the cultivation. The growth of G.
lucidum was quite poor when the DO was controlled to
be at 10 % of air saturation, which appears to be due to
the limited oxygen availability in the interior of the my-
celial aggregates. Despite the poor growth, the produc-
tion of extracellular polysaccharides (EPS) and the con-
tents of IPS and GA within the biomass at a DO of 10 %
were higher than those obtained at DO of 25 %. How-
ever, the overall yields and productivities of IPS and GA
at lower DO were lower than those at the higher DO.
Mao and Zhong (11) investigated the effect of oxy-
gen supply on cordycepin production in submerged cul-
tivation of Cordyceps militaris in a 5-litre turbine-agitated
bioreactor. Initial KLa values influenced cordycepin pro-
duction significantly over the range from 11.5 to 113.8
h–1. The highest cordycepin concentration of 168 mg/L
was obtained at an initial KLa value of 54.5 h
–1.
Shear force and mixing
In submerged cultures of mushroom, it is necessary
to agitate the culture broth in order to obtain good mix-
ing and thereby promote heat and mass transfer. How-
ever, agitation also creates shear force. This shear force
can cause damage to hyphae and provoke morphologi-
cal changes in the mycelium, and these changes can
cause variations in growth rate and product formation
(54).
Gong and Zhong (55) studied the influence of shear
force on growth and production of ganoderic acid and
polysaccharides by G. lucidum in stirred tank bioreac-
tors. The parameter used to characterize the shear force
was the tip speed of the impeller. The tip speed signifi-
cantly affected the maximum biomass concentration ob-
tained over the range from 0.51 to 1.53 m/s in a 5-litre
stirred bioreactor: with a tip speed of 0.51 m/s, the max-
imum biomass concentration obtained after 9 days of
cultivation was 13.8 g/L, whereas at a tip speed of 1.53
m/s it was only 10.6 g/L. The mycelial morphology of
G. lucidum was also affected by the tip speed. During
the first 3 days of cultivation, the mean projected area of
dispersed hypha increased much more at a tip speed of
0.51 m/s than at higher tip speeds. The maximum mean
projected areas of dispersed hypha obtained were 3.7·104,
2.5·104 and 2.1·104 mm2 with impeller tip speeds of 0.51,
1.02, and 1.53 m/s, respectively. The pellet size at the
lowest tip speed (0.51 m/s) increased more rapidly than
it did at the higher tip speeds (1.02 or 1.53 m/s). In
other words, smaller pellets and shorter hyphae were
formed under conditions of higher shear stress. A lower
shear environment also favored IPS accumulation. On
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the other hand, EPS accumulation was not affected much
by the tip speed. Finally, the optimum production of GA
occurred at the intermediate tip speed, 1.02 m/s.
In fact, there has been relatively little research into
culture broth mixing and rheology in the cultivation of
mushrooms. These issues have received more attention
in the case of other microorganims (56), with studies fo-
cusing on: (i) the effects of impeller design and opera-
tion on the development of rheology and texture; (ii)
empirical measurement of rheology during mixing from
mixer torque or power consumption; (iii) effect of rheol-
ogy on mixing patterns and performance; and (iv) simu-
lation and prediction of mixing flow deformation pat-
terns as functions of impeller geometry and rheology.
Morphology and rheology
Cell morphology and broth rheology affect the me-
tabolism of mushroom during submerged fermentations
in bioreactors (57). Changes in mycelial morphology and
the consequent changes in broth rheology affect several
phenomena, such as mass and heat transfer, oxygen up-
take and carbon dioxide evolution, shear stress and mix-
ing efficiency. Unfortunately, the relationship between
growth morphology and metabolite production by mush-
rooms is not well understood (58). The multicellular
structure of the mycelium, which allows morphological
and physiological heterogeneity to occur along the length
of hyphae during the culture, makes it difficult to con-
struct mathematical models to predict culture perfor-
mance and to guide control strategies (59).
One or both of two growth forms occur during the
cultivation of most mushroom in submerged culture: the
filamentous and the pellet form (60). Often the morphol-
ogy of the filamentous element is simply characterized
by the total hyphal length and the number of actively
growing tips. The morphology of pellets is characterized
by the pellet shape (degree of circularity), the pellet di-
ameter, the area covered by the pellet, and the hairiness
and roughness of the pellet.
Fang et al. (61) investigated the impact of pellet size
on the biosynthesis of intracellular polysaccharides (IPS)
and ganoderic acid (GA) by G. lucidum. The contents of
IPS in pellets decreased as the pellet diameter increased,
being 85, 69 and 55 mg/g (dry mass basis) for diameters
smaller than 1.2 mm, from 1.2 to 1.6 mm, and larger
than 1.6 mm, respectively. In contrast, the content of GA
increased with pellet size, being 10, 13 and 16 mg/g
(dry mass basis), respectively, for the same three pellet
sizes listed above. Mycelial pellet size therefore has dif-
ferent effects on formation of polysaccharide and gano-
deric acid in G. lucidum cultures (61).
Many operating variables affect the cell morphology
and broth rheology during submerged cultivation of
mushrooms in bioreactors, including the inoculation
density, culture pH, temperature and nutrient supply.
Although these effects have not been extensively stud-
ied, some observations have been made and are pre-
sented in the following paragraphs.
In the case of G. lucidum, the study of Fang et al.
(61) showed a decrease in pellet size as inoculation den-
sity increased. With an inoculum size of 670 mg/L (dry
mass basis), 68 % of the pellets had diameters smaller
than 1.2 mm; however, at an inoculum size of 70 mg/L
(dry mass basis), 91 % of the pellets had diameters
larger than 1.6 mm.
During the submerged fermentation of G. lucidum in
an airlift bioreactor without pH control, Lee et al. (62)
observed a change in mycelial morphology from an ini-
tial pellet-like form to a filamentous form. On the other
hand, when the pH was controlled at 6, the mycelial
morphology was pellet-like throughout the whole cul-
ture period.
Pellet size and hairy mycelial length in a submerged
fermentation of G. lucidum were significantly affected by
mechanical forces. In a novel two-stage cultivation pro-
cess of G. lucidum developed by Fang and Zhong (63),
and Tang and Zhong (64), flasks were shaken for the
first four days and then left static. An interesting phe-
nomenon was that a white mycelium layer appeared on
the surface of culture broth and that this layer produced
a higher yield of ganoderic acid than was obtained in
the conventional submerged fermentation (63,64).
The aeration rate can affect the morphology signifi-
cantly. When Cordyceps militaris was grown under differ-
ent aeration conditions, it always grew in pellet form,
but the morphology of the pellets varied notably. The
mean diameter and compactness of the pellets were
higher at 2 vvm, a condition that also favored exobio-
polymer biosynthesis. In cultures grown at 0.5 vvm, the
core of the pellets autolyzed during the later stages of
the fermentation, whereas in cultures grown at 4 vvm
the outer hairy region of the pellet was sheared off (65).
In their studies on the effect of KLa on the rate on
the growth and production formation by G. lucidum de-
scribed above, Tang and Zhong (53) also showed that
KLa affected pellet morphology. In these studies the vari-
ations in the initial KLa were obtained by adjusting the
aeration rate and keeping the agitation rate constant.
The mycelium from cultures grown with the highest ini-
tial KLa value was more aggregated than the mycelium
grown with lower initial KLa values. An increase of ini-
tial KLa from 16.4 to 78.2 h
–1 increased the percentage of
mycelial aggregates with diameters larger than 0.5 mm
and also those with diameters between 0.25 and 0.5 mm,
while the percentage of mycelial aggregates with diame-
ters below 0.25 mm decreased. When the initial KLa was
increased further to 96.0 h-1, there was a big increase in
the percentage of mycelial aggregates over 0.50 mm in
diameter.
The rheological characteristics of the broth during
the culture of mushrooms are strongly influenced by the
yield of mycelial biomass, the morphological form of
this biomass and the production of extracellular poly-
mers (16). High biomass and extracellular polymer yields
lead to large increases in the viscosity of the culture
broth during the fermentation. As a result, it can be dif-
ficult to achieve good nutrient and oxygen transfer out-
side the zone swept by the impeller. With respect to the
morphological form, cultures in which the mushroom
grows as pellets tend to be less viscous than those in
which it grows as dispersed filaments. When growth oc-
curs in the pellet form, the culture broth typically only
becomes viscous and deviates from Newtonian behavior
at high biomass concentrations (66).
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Two-stage culture process
It is not uncommon for the optimal conditions for
cell growth to be quite different from those for product
biosynthesis. Directed shifting of process parameters can
be used to optimize cell and product yields. However, a
successful application of process parameter shifts re-
quires a good understanding of the physiological changes
that are provoked within the cells.
Lee et al. (62) proposed a bistage pH control process
for improving EPS production by G. lucidum in an airlift
bioreactor. Starting with a pH of 3 and changing this to
6 at the beginning of the exponential growth phase al-
lowed an EPS yield of 20 g/L, compared to the yield of
4.1 g/L obtained in the culture without pH control (62).
This strategy avoided the adverse effects on growth that
occurred when the pH was maintained constant at 6
throughout the whole culture period.
Based on an analysis of the relationship between the
specific rate of formation of cordycepin and DO in sub-
merged cultivation of Cordyceps militaris, Mao and Zhong
(11) developed a two-stage DO control strategy to main-
tain a high specific rate of cordycepin formation. The
DO was controlled at 60 % of air saturation in the initial
stages of the cultivation and then shifted to 30 % of air
saturation when the specific rate of cordycepin forma-
tion started to decrease. With this strategy they were
able to obtain a high cordycepin yield of 201 mg/L and
a high productivity of 15.5 mg/(L·day), these values be-
ing 15 and 30 % higher, respectively, than the values ob-
tained in conventional experiments in which the DO was
maintained constant. The proposed DO control strategy
was also applied to a 5-litre centrifugal impeller biore-
actor, with the cordycepin yield and productivity being
188.3 mg/L and 14.5 mg/(L·day), respectively. The pro-
cess was also successfully scaled up from the 5-litre bio-
reactor to a 30-litre bioreactor of the same type.
In our own work, a two-stage fermentation process
of G. lucidum was developed for enhanced GA produc-
tion by combining the first stage comprised of a conven-
tional shake-flask culture with the second stage com-
prised of static culture. The first stage was realized with
agitation in a rotary shaker. After 4, 8 or 12 days, the ag-
itation was stopped and the culture then remained static
until the 24th day. A control culture was shaken for the
whole time. In the static culture process, glucose was
consumed at a slower rate and converted to biomass
more efficiently. The highest cell density, 21 g/L (dry
mass basis), was achieved through a 4-day shake-flask
fermentation followed by a 12-day static culture. The
GA production in this two-stage process was consider-
ably enhanced, with its content in the biomass increas-
ing from 14 (shaken control) to 32 mg/g, the latter result
being much higher than previously obtained (63,64). A
thick layer of white mycelia formed on the liquid sur-
face during the static culture.
Scale-up of the static second stage was studied in
order to improve GA production. The initial volumetric
oxygen transfer coefficient (KLa) and the area of liquid
surface per liquid volume (As) were identified as key
factors affecting the process. A multilayer static biore-
actor was designed on the basis of these parameters. At
a low initial KLa level of 2.1 h
–1, a thick layer of white
mycelia formed on the liquid surface, and an optimal to-
tal yield of GA was obtained, taking into account the
GA produced both in the liquid and in the white myce-
lial layer. In the case of As, both the formation of white
mycelia and production of GA in the mycelial layer at
the liquid surface increased as As increased from 0.24 to
1.53 cm2/mL. On the other hand, the total yield of GA
was optimal at an As value of 0.90 cm
2/mL. The process
was scaled up successfully from a 20-mL static T-flask to
a 7.5-litre three-layer static bioreactor, by maintaining the
initial KLa constant. The maximum biomass (21 g/L, dry
basis), GA content (50 mg/g, dry basis), and total GA
production (1.0 g/L) were attained in static bioreactors.
A simple unstructured kinetic model was construct-
ed to describe this novel static culture process (67). Pa-
rameters in the model were determined by fitting the
model to the experimental data. The model was able to
describe the dynamics of cell growth, substrate consump-
tion and GA accumulation by G. lucidum cells. A param-
eter sensitivity analysis indicated that the model predic-
tions were sensitive to changes in the maximum specific
growth rate, the saturation constant, the biomass yield
on lactose and the growth-associated product formation
constant. The model was able to predict the static cul-
ture process of G. lucidum in various laboratory-scale
multilayer static bioreactors with working volumes from
20 mL to 7.5 L. The model might be useful in guiding
the scale-up of the process to industrial scale.
Conclusions and Perspectives
The study and manufacture of products by sub-
merged fermentation of mushrooms confronts us with
numerous difficulties. In recent years, considerable en-
deavor has been made in monitoring and control of the
cultures of mushrooms, but relatively little headway has
been made in this area, despite widespread acknowledg-
ment of the limitation of existing bioreactors.
Another area of comparative neglect has been the
study of the behavior of mushrooms in bioreactors. Gra-
dients in the concentrations of substrate and other che-
mical species are especially pronounced in submerged
cultures of mushrooms, yet our knowledge of how mush-
rooms behave when exposed to changes in their envi-
ronment is scanty. Fortunately, our ability to carry out
such studies is improving, due to the increasingly so-
phisticated techniques that are becoming available to stu-
dy the internal processes of cells. A better knowledge of
how mushrooms behave in varying environments would
permit the design of processes and bioreactors around
the capabilities of the fungus. Such knowledge of mush-
rooms does not obviate the need for fundamental stud-
ies related to control of bioreactor performance; in fact,
the need for close cooperation between the chemical en-
gineer and the microbial physiologist has never been
greater.
As pointed out in this review, the submerged cul-
ture of mushrooms has significant industrial potential,
but its success on a commercial scale depends on costs
compared to the existing field-cultivation technology
and whether industry sees an economic advantage. In-
creases in productivity through the optimization of cul-
227Y.-J. TANG et al.: Submerged Cultivation of Mushrooms, Food Technol. Biotechnol. 45 (3) 221–229 (2007)
ture conditions and bioreactor operating strategies will
help to realize the commercialization of these processes.
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